Larvol Delta - OBI-Pharma-granted-FDA-Orphan-Drug-Designation-for-OBI3424-for-the-treatment-of-acute-lymphoblastic-leukemia-ALL

OBI-3424 - OBI Pharma

https://www.prnewswire.com/news-releases/obi-pharma-granted-fda-orphan-drug-designation-for-obi-3424-for-the-treatment-of-acute-lymphoblastic-leukemia-all-300715156.html

Sep 19, 2018

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next